Current Issue 3 February 2012, Vol. 586, No. 3

Issue Highlights

Research Letters with SDA

  • C-terminal residues of Oryza sativa GUN4 are required for the activation of the ChlH subunit of magnesium chelatase in chlorophyll synthesis
    3 February 2012(Vol. 586 | No. 3 | Pages 205-210)

    Shuaixiang Zhou, Artur Sawicki, Robert D. Willows, Meizhong Luo

  • FLU, a negative feedback regulator of tetrapyrrole biosynthesis, is physically linked to the final steps of the Mg++-branch of this pathway
    3 February 2012(Vol. 586 | No. 3 | Pages 211-216)

    Dominika Kauss, Sylvain Bischof, Sandro Steiner, Klaus Apel, Rasa Meskauskiene

  • Activation of macrophage-stimulating protein by human airway trypsin-like protease
    3 February 2012(Vol. 586 | No. 3 | Pages 217-221)

    Hiroshi Orikawa, Makiko Kawaguchi, Takashi Baba, Kenji Yorita, Sumio Sakoda, Hiroaki Kataoka

  • Activation of spleen tyrosine kinase is required for TNF-α-induced endothelin-1 upregulation in human aortic endothelial cells
    06 February 2012

    Yoon Ji Kim, Tai Yeon Koo, Won Seok Yang, Nam Jeong Han, Jin Uk Jeong, Sang Koo Lee, Su-Kil Park

  • Asp563 of the horizontal helix of subunit NuoL is involved in proton translocation by the respiratory complex I
    06 February 2012

    Stefan Steimle, Max Willistein, Patricia Hegger, Marco Janoschke, Heiko Erhardt, Thorsten Friedrich

  • Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer
    06 February 2012

    Stephen P. Malkoski, Xiao-Jing Wang

  • Insights into differential modulation of receptor function by hinge region using novel agonistic lutropin receptor and inverse agonistic thyrotropin receptor antibodies
    03 February 2012

    Ritankar Majumdar, Reema Railkar, Rajan R Dighe

  • Construction of synthetic regulatory networks in yeast
    03 February 2012

    Benjamin A. Blount, Tim Weenink, Tom Ellis

    • View More Articles in Press...



On the Cover


Cover Image

New Issue Alert

More About FEBS

FEBS, since its inception in 1964, has promoted life sciences and supported scientists in Europe and elsewhere, and is one of the largest not-for-profit organizations in life sciences today. Among the offers to our members are participation in advance courses, the support of fellowships and participation in our annual Congress. All activities related to FEBS are financed by income generated by our four publications: FEBS Letters, FEBS Journal, Molecular Oncology, and FEBS OpenBio. As reader or author of papers in these journals, you contribute to our mission: To foster scientific excellence and promote science for society. Thank you for your support. For more information on FEBS, please visit www.febs.org.

Publishing Information

FEBS Letters is published by Elsevier BV on behalf of the Federation of European Biochemical Societies.



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Announcements

FEBS Letters Structured Digital Abstracts Experiment

Protein interaction papers to have Structured Digital Summary

Read the Press Release for more details and explanation of this innovative experiment.

Past Announcements

Special Issues

      

Virtual Special Issues

FEBS Letters is proud to launch a new series of Virtual Special Issues which will highlight a collection of outstanding articles recently published in the journal, focusing on a selection of topics that we hope will be of general interest to our readers.